)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Stoke Therapeutics
Stoke Therapeutics (STOK) investor relations material
Stoke Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary22 Apr, 2026
Executive summary
Annual meeting scheduled for June 3, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 2, 2026.
Voting matters and shareholder proposals
Election of three Class I directors to serve until the 2029 annual meeting or until successors are elected.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote to approve compensation of named executive officers.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Nominees for Class I director positions are G. Clare Kahn, Ph.D., Adrian Krainer, Ph.D., and Julie Anne Smith.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Stoke Therapeutics
- Phase III Dravet study nears full enrollment, with strong efficacy and market positioning.STOK
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - Board recommends approval of director elections, auditor, and executive pay; strong governance and oversight.STOKProxy filing23 Apr 2026
- Zorevunersen shows sustained efficacy and cognitive gains, with phase III readout expected mid-2027.STOK25th Annual Needham Virtual Healthcare Conference14 Apr 2026
- Four-year data show durable seizure reduction and cognitive gains, with phase 3 readout in 2027.STOKGuggenheim Securities Emerging Outlook: Biotech Summit 202610 Apr 2026
- 2025 revenue jumped to $184.4M, net loss narrowed, and cash runway extends into 2028.STOKQ4 202516 Mar 2026
- Global phase III for Dravet syndrome advances, with robust efficacy and cognitive data supporting design.STOKTD Cowen Genetic Medicines & RNA Summit3 Feb 2026
- Zorevunersen delivers sustained seizure and cognitive improvements in Dravet syndrome, with phase III plans advancing.STOKGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Zorevunersen delivers durable seizure and cognitive gains in Dravet, with phase III set for next year.STOKH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Lead candidate shows 80% seizure reduction and cognitive gains in Dravet, with pivotal trial plans underway.STOK2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
Next Stoke Therapeutics earnings date
Q1 20267 May, 2026
Stoke Therapeutics
Next Stoke Therapeutics earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage